OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
N6-methyladenosine demethylase FTO suppressed prostate cancer progression by maintaining CLIC4 mRNA stability
Libin Zou, Wenbin Chen, Xumin Zhou, et al.
Cell Death Discovery (2022) Vol. 8, Iss. 1
Open Access | Times Cited: 31
Libin Zou, Wenbin Chen, Xumin Zhou, et al.
Cell Death Discovery (2022) Vol. 8, Iss. 1
Open Access | Times Cited: 31
Showing 1-25 of 31 citing articles:
FTO promotes cervical cancer cell proliferation, colony formation, migration and invasion via the regulation of the BMP4/Hippo/YAP1/TAZ pathway
Jinyuan Huang, Jing Yang, Yudi Zhang, et al.
Experimental Cell Research (2023) Vol. 427, Iss. 1, pp. 113585-113585
Closed Access | Times Cited: 21
Jinyuan Huang, Jing Yang, Yudi Zhang, et al.
Experimental Cell Research (2023) Vol. 427, Iss. 1, pp. 113585-113585
Closed Access | Times Cited: 21
FTO-stabilized miR-139–5p targets ZNF217 to suppress prostate cancer cell malignancies by inactivating the PI3K/Akt/mTOR signal pathway
Baihetiya Azhati, Aerziguli Reheman, Diliyaer Dilixiati, et al.
Archives of Biochemistry and Biophysics (2023) Vol. 741, pp. 109604-109604
Closed Access | Times Cited: 17
Baihetiya Azhati, Aerziguli Reheman, Diliyaer Dilixiati, et al.
Archives of Biochemistry and Biophysics (2023) Vol. 741, pp. 109604-109604
Closed Access | Times Cited: 17
RNA N6-methyladenosine modifications in urological cancers: from mechanism to application
Lei Yang, Jianming Ying, Qian Tao, et al.
Nature Reviews Urology (2024) Vol. 21, Iss. 8, pp. 460-476
Closed Access | Times Cited: 7
Lei Yang, Jianming Ying, Qian Tao, et al.
Nature Reviews Urology (2024) Vol. 21, Iss. 8, pp. 460-476
Closed Access | Times Cited: 7
Zhaotong Wang, Jiawang Zhou, Haisheng Zhang, et al.
Molecular Oncology (2022) Vol. 17, Iss. 2, pp. 195-229
Open Access | Times Cited: 28
FTO Inhibits Epithelial Ovarian Cancer Progression by Destabilising SNAI1 mRNA through IGF2BP2
Meige Sun, Xiaocui Zhang, Fangfang Bi, et al.
Cancers (2022) Vol. 14, Iss. 21, pp. 5218-5218
Open Access | Times Cited: 26
Meige Sun, Xiaocui Zhang, Fangfang Bi, et al.
Cancers (2022) Vol. 14, Iss. 21, pp. 5218-5218
Open Access | Times Cited: 26
Demethylases in tumors and the tumor microenvironment: Key modifiers of N6-methyladenosine methylation
Junchen Guo, Liang Zhao, Meiqi Duan, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 174, pp. 116479-116479
Open Access | Times Cited: 5
Junchen Guo, Liang Zhao, Meiqi Duan, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 174, pp. 116479-116479
Open Access | Times Cited: 5
The role of RNA-modifying proteins in renal cell carcinoma
Muna A. Ali, Khuloud Bajbouj, Iman M. Talaat, et al.
Cell Death and Disease (2024) Vol. 15, Iss. 3
Open Access | Times Cited: 4
Muna A. Ali, Khuloud Bajbouj, Iman M. Talaat, et al.
Cell Death and Disease (2024) Vol. 15, Iss. 3
Open Access | Times Cited: 4
RNA m6a Methylation Regulator Expression in Castration-Resistant Prostate Cancer Progression and Its Genetic Associations
Chamikara Liyanage, Achala Fernando, Audrey Chamberlain, et al.
Cancers (2024) Vol. 16, Iss. 7, pp. 1303-1303
Open Access | Times Cited: 4
Chamikara Liyanage, Achala Fernando, Audrey Chamberlain, et al.
Cancers (2024) Vol. 16, Iss. 7, pp. 1303-1303
Open Access | Times Cited: 4
The relationship between the network of non-coding RNAs-molecular targets and N6-methyladenosine modification in tumors of urinary system
Ruiming Li, Zhu Chunming, Yuan Wang, et al.
Cell Death and Disease (2024) Vol. 15, Iss. 4
Open Access | Times Cited: 4
Ruiming Li, Zhu Chunming, Yuan Wang, et al.
Cell Death and Disease (2024) Vol. 15, Iss. 4
Open Access | Times Cited: 4
FTO triggers NLRP3/GSDMD-dependent pyroptosis to enhance cisplatin-sensitivity in ovarian cancer
Fubin Zhang, Tianhong Zhu, Lei Gan, et al.
Cellular Signalling (2025), pp. 111698-111698
Closed Access
Fubin Zhang, Tianhong Zhu, Lei Gan, et al.
Cellular Signalling (2025), pp. 111698-111698
Closed Access
The role of chloride intracellular channel 4 in tumors
Xin Li, Yongfeng Wang, Minmin Ren, et al.
Cancer Cell International (2025) Vol. 25, Iss. 1
Open Access
Xin Li, Yongfeng Wang, Minmin Ren, et al.
Cancer Cell International (2025) Vol. 25, Iss. 1
Open Access
RNA-binding protein DND1 participates in migration, invasion, and EMT of prostate cancer cells by degrading CLIC4.
Wei Zhang, Qian Xu, Chunmei Shi, et al.
PubMed (2024) Vol. 39, Iss. 10, pp. 1343-1358
Closed Access | Times Cited: 3
Wei Zhang, Qian Xu, Chunmei Shi, et al.
PubMed (2024) Vol. 39, Iss. 10, pp. 1343-1358
Closed Access | Times Cited: 3
Comprehensive Analysis and Functional Characteristics of Differential Expression of N6-Methyladenosine Methylation Modification in the Whole Transcriptome of Rheumatoid Arthritis
Lei Wan, Jian Liu, Chuanbing Huang, et al.
Mediators of Inflammation (2022) Vol. 2022, pp. 1-14
Open Access | Times Cited: 15
Lei Wan, Jian Liu, Chuanbing Huang, et al.
Mediators of Inflammation (2022) Vol. 2022, pp. 1-14
Open Access | Times Cited: 15
Targeting the m6A mRNA demethylase FTO suppresses vascular endothelial growth factor release and choroidal neovascularization
Shao-Bin Wang, Yosuke Nagasaka, Dionne Argyle, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 9
Shao-Bin Wang, Yosuke Nagasaka, Dionne Argyle, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 9
RNA m6A modification in prostate cancer: A new weapon for its diagnosis and therapy
Zeyu Han, Xianyanling Yi, Jin Li, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2023) Vol. 1878, Iss. 5, pp. 188961-188961
Closed Access | Times Cited: 7
Zeyu Han, Xianyanling Yi, Jin Li, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2023) Vol. 1878, Iss. 5, pp. 188961-188961
Closed Access | Times Cited: 7
ZFHX3 acts as a tumor suppressor in prostate cancer by targeting FTO-mediated m6A demethylation
Qingxia Hu, Junling Yin, Sijie Zhao, et al.
Cell Death Discovery (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 2
Qingxia Hu, Junling Yin, Sijie Zhao, et al.
Cell Death Discovery (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 2
Interplay between m6A epitranscriptome and epigenome in cancer: current knowledge and therapeutic perspectives
Guglielmo Bove, Sajid Amin, Mehrad Babaei, et al.
International Journal of Cancer (2022) Vol. 153, Iss. 3, pp. 464-475
Open Access | Times Cited: 11
Guglielmo Bove, Sajid Amin, Mehrad Babaei, et al.
International Journal of Cancer (2022) Vol. 153, Iss. 3, pp. 464-475
Open Access | Times Cited: 11
The functions and mechanisms of RNA modification in prostate: Current status and future perspectives
Zhijin Zhang, Ji Liu, Yang Wu, et al.
Frontiers in Genetics (2024) Vol. 15
Open Access | Times Cited: 1
Zhijin Zhang, Ji Liu, Yang Wu, et al.
Frontiers in Genetics (2024) Vol. 15
Open Access | Times Cited: 1
Role of N6‑methyladenosine in the pathogenesis, diagnosis and treatment of prostate cancer (Review)
Junjie Pan, Fei Tong, Ning Ren, et al.
Oncology Reports (2024) Vol. 51, Iss. 6
Open Access | Times Cited: 1
Junjie Pan, Fei Tong, Ning Ren, et al.
Oncology Reports (2024) Vol. 51, Iss. 6
Open Access | Times Cited: 1
Molecular predictors of metastasis in patients with prostate cancer
Jundong Lin, Yangjia Zhuo, Yuting Zhang, et al.
Expert Review of Molecular Diagnostics (2023) Vol. 23, Iss. 3, pp. 199-215
Closed Access | Times Cited: 3
Jundong Lin, Yangjia Zhuo, Yuting Zhang, et al.
Expert Review of Molecular Diagnostics (2023) Vol. 23, Iss. 3, pp. 199-215
Closed Access | Times Cited: 3
The functional roles of m6A modification in prostate cancer
Fa Zhang, Feng Chen, Chao Wang, et al.
PROTEOMICS - CLINICAL APPLICATIONS (2023) Vol. 17, Iss. 6
Closed Access | Times Cited: 3
Fa Zhang, Feng Chen, Chao Wang, et al.
PROTEOMICS - CLINICAL APPLICATIONS (2023) Vol. 17, Iss. 6
Closed Access | Times Cited: 3
The emerging roles and mechanism of N6-methyladenosine (m6A) modifications in urologic tumours progression
Wenhao Zhu, Renshan Zhao, Xiaomin Guan, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 3
Wenhao Zhu, Renshan Zhao, Xiaomin Guan, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 3
The role of RNA modification in urological cancers: mechanisms and clinical potential
Xuming Zhou, Hezhen Zhu, Cong Luo, et al.
Discover Oncology (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 3
Xuming Zhou, Hezhen Zhu, Cong Luo, et al.
Discover Oncology (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 3
Research progress of m6A methylation in prostate cancer
Shouyi Zhang, Yu Zeng
Asian Journal of Andrology (2022) Vol. 25, Iss. 2, pp. 166-170
Open Access | Times Cited: 4
Shouyi Zhang, Yu Zeng
Asian Journal of Andrology (2022) Vol. 25, Iss. 2, pp. 166-170
Open Access | Times Cited: 4
Demethylase FTO inhibits the development of prostate cancer by upregulating EGR2 expression in an m6A manner
Zhenyu Wang, Huamin Sun, Hua Zhu, et al.
TURKISH JOURNAL OF BIOLOGY (2022) Vol. 46, Iss. 6, pp. 426-438
Open Access | Times Cited: 4
Zhenyu Wang, Huamin Sun, Hua Zhu, et al.
TURKISH JOURNAL OF BIOLOGY (2022) Vol. 46, Iss. 6, pp. 426-438
Open Access | Times Cited: 4
